Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
Elg M, Gustafsson D, Deinum J. Elg M, et al. Thromb Haemost. 1997 Oct;78(4):1286-92. Thromb Haemost. 1997. PMID: 9364999
Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat.
Elg M, Gustafsson D, Carlsson S. Elg M, et al. Thromb Res. 1999 May 1;94(3):187-97. doi: 10.1016/s0049-3848(98)00213-8. Thromb Res. 1999. PMID: 10326765
Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes.
Gustafsson D, Antonsson T, Bylund R, Eriksson U, Gyzander E, Nilsson I, Elg M, Mattsson C, Deinum J, Pehrsson S, Karlsson O, Nilsson A, Sörensen H. Gustafsson D, et al. Among authors: elg m. Thromb Haemost. 1998 Jan;79(1):110-8. Thromb Haemost. 1998. PMID: 9459334
Raised plasma concentrations of endothelin-1 and -3 in marmosets with acute aortic stenosis: no relation to the renin-angiotensin system.
Gustafsson D, Elg M, Hedner T, Johnsson E, Sohtell M, Svensson L, Fyhrquist F. Gustafsson D, et al. Among authors: elg m. Blood Press. 1992 May;1(1):50-6. doi: 10.3109/08037059209065124. Blood Press. 1992. PMID: 1345144
Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.
Gustafsson D, Elg M, Lenfors S, Börjesson I, Teger-Nilsson AC. Gustafsson D, et al. Among authors: elg m. Blood Coagul Fibrinolysis. 1996 Jan;7(1):69-79. doi: 10.1097/00001721-199601000-00009. Blood Coagul Fibrinolysis. 1996. PMID: 8845466
The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: reply.
Hansson KM, Elg M, Deinum J. Hansson KM, et al. Among authors: elg m. J Thromb Haemost. 2015 Aug;13(8):1530-2. doi: 10.1111/jth.13029. Epub 2015 Jul 15. J Thromb Haemost. 2015. PMID: 26094693 Free article. No abstract available.
The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood.
Hansson KM, Nielsen S, Elg M, Deinum J. Hansson KM, et al. Among authors: elg m. J Thromb Haemost. 2014 Oct;12(10):1678-86. doi: 10.1111/jth.12707. Epub 2014 Sep 30. J Thromb Haemost. 2014. PMID: 25142753
Single-dose pharmacokinetics, pharmacodynamics and safety of AZD0837, a novel oral direct thrombin inhibitor, in young healthy male subjects.
Johansson S, Cullberg M, Eriksson UG, Elg M, Dunér K, Jensen E, Wollbratt M, Wåhlander K. Johansson S, et al. Among authors: elg m. Int J Clin Pharmacol Ther. 2011 Apr;49(4):258-67. doi: 10.5414/CP201465. Int J Clin Pharmacol Ther. 2011. PMID: 21429440
Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Pehrsson S, Johansson K, Kjaer M, Elg M. Pehrsson S, et al. Among authors: elg m. Thromb Haemost. 2010 Dec;104(6):1242-9. doi: 10.1160/TH09-10-0744. Epub 2010 Aug 30. Thromb Haemost. 2010. PMID: 20806126
The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by alpha-macroglobulin-thrombin.
Wagenvoord RJ, Deinum J, Elg M, Hemker HC. Wagenvoord RJ, et al. Among authors: elg m. J Thromb Haemost. 2010 Jun;8(6):1281-9. doi: 10.1111/j.1538-7836.2010.03822.x. Epub 2010 Feb 24. J Thromb Haemost. 2010. PMID: 20180821
54 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback